Braun Stacey Associates’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-143,140
Closed -$10.3M 129
2023
Q1
$10.3M Buy
+143,140
New +$11.2M 0.27% 99
2018
Q2
Sell
-144,508
Closed -$12M 125
2018
Q1
$12M Buy
144,508
+6,570
+5% +$592K 0.83% 68
2017
Q4
$13.1M Sell
137,938
-2,567
-2% -$268K 0.88% 56
2017
Q3
$16.4M Sell
140,505
-16,025
-10% -$2.03M 1.12% 30
2017
Q2
$19.7M Buy
156,530
+13,055
+9% +$1.66M 1.28% 14
2017
Q1
$19.2M Buy
+143,475
New +$18.3M 1.22% 19

Other funds holding INCY

Braun Stacey Associates's INCY Position: Q2 2023 in Review

Braun Stacey Associates sold out of Incyte (INCY) in Q2 2023, closing a stake of 143,140 shares — an estimated $10.3M sold.

Braun Stacey Associates first reported a position in INCY in Q1 2017 and held it in 6 quarters. The position peaked at $19.7M in Q2 2017. 528 funds tracked by Wall St. Rank hold INCY as of Q2 2023.

  • Braun Stacey Associates reported no remaining Incyte position as of Q2 2023 after selling out during the quarter.
  • Braun Stacey Associates sold 143,140 Incyte shares in Q2 2023, an estimated $10.3M.
  • Braun Stacey Associates first reported a position in Incyte in Q1 2017 and held it in 6 quarters.
  • Braun Stacey Associates's Incyte position peaked at $19.7M in Q2 2017.
  • 528 funds tracked by Wall St. Rank held Incyte as of Q2 2023.

Based on Braun Stacey Associates's 13F filing for Q2 2023, filed 28 Jul 2023.